109 related articles for article (PubMed ID: 23527717)
1. Clinical significance of pituitary tumor transforming gene 1 and transgelin-2 in pancreatic cancer.
Lin H; Chen QL; Wang XY; Han W; He TY; Yan D; Chen K; Su LD
Int J Immunopathol Pharmacol; 2013; 26(1):147-56. PubMed ID: 23527717
[TBL] [Abstract][Full Text] [Related]
2. Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics.
Jin H; Cheng X; Pei Y; Fu J; Lyu Z; Peng H; Yao Q; Jiang Y; Luo L; Zhuo H
J Proteomics; 2016 Mar; 136():77-88. PubMed ID: 26721444
[TBL] [Abstract][Full Text] [Related]
3. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
Cell Signal; 2024 Aug; 120():111227. PubMed ID: 38744388
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of immunogenic cell death biomarker rage and early growth response 1 in human primary gastric adenocarcinoma.
Xu XC; Gao H; Zhang WB; Abuduhadeer X; Wang YH
Int J Immunopathol Pharmacol; 2013; 26(2):485-93. PubMed ID: 23755764
[TBL] [Abstract][Full Text] [Related]
5. A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility.
Leung WK; Ching AK; Chan AW; Poon TC; Mian H; Wong AS; To KF; Wong N
Oncogene; 2011 Nov; 30(44):4464-75. PubMed ID: 21577206
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a polyclonal antibody to human pituitary tumor transforming gene 1 (PTTG1) protein.
Kakar SS; Chen L; Puri R; Flynn SE; Jennes L
J Histochem Cytochem; 2001 Dec; 49(12):1537-46. PubMed ID: 11724901
[TBL] [Abstract][Full Text] [Related]
8. Expression of pituitary-tumour transforming gene in colorectal tumours.
Heaney AP; Singson R; McCabe CJ; Nelson V; Nakashima M; Melmed S
Lancet; 2000 Feb; 355(9205):716-9. PubMed ID: 10703804
[TBL] [Abstract][Full Text] [Related]
9. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma.
Ishitsuka Y; Kawachi Y; Taguchi S; Maruyama H; Nakamura Y; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
Exp Dermatol; 2013 May; 22(5):318-22. PubMed ID: 23489647
[TBL] [Abstract][Full Text] [Related]
11. Expression of pituitary tumor transforming gene in human gastric carcinoma.
Wen CY; Nakayama T; Wang AP; Nakashima M; Ding YT; Ito M; Ishibashi H; Matsuu M; Shichijo K; Sekine I
World J Gastroenterol; 2004 Feb; 10(4):481-3. PubMed ID: 14966902
[TBL] [Abstract][Full Text] [Related]
12. Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer.
Jo JH; Park SB; Chung J; Oh T; Lee HS; Chung MJ; Park JY; Bang S; Park SW; Jung DE; Song SY
BMC Cancer; 2024 Mar; 24(1):357. PubMed ID: 38509504
[TBL] [Abstract][Full Text] [Related]
13. Functional significance of transgelin-2 in uterine cervical squamous cell carcinoma.
Yakabe K; Murakami A; Kajimura T; Nishimoto Y; Sueoka K; Sato S; Nawata S; Sugino N
J Obstet Gynaecol Res; 2016 May; 42(5):566-72. PubMed ID: 26891454
[TBL] [Abstract][Full Text] [Related]
14. Significance of pituitary tumor transforming gene 1 (PTTG1) in prostate cancer.
Zhu X; Mao Z; Na Y; Guo Y; Wang X; Xin D
Anticancer Res; 2006; 26(2A):1253-9. PubMed ID: 16619532
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer.
Zhang ML; Lu S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):313-7. PubMed ID: 18522889
[TBL] [Abstract][Full Text] [Related]
16. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.
Horwitz GA; Miklovsky I; Heaney AP; Ren SG; Melmed S
Mol Endocrinol; 2003 Apr; 17(4):600-9. PubMed ID: 12554778
[TBL] [Abstract][Full Text] [Related]
17. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.
Vlotides G; Cruz-Soto M; Rubinek T; Eigler T; Auernhammer CJ; Melmed S
Mol Endocrinol; 2006 Dec; 20(12):3321-35. PubMed ID: 16959877
[TBL] [Abstract][Full Text] [Related]
19. Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer.
Shibata Y; Haruki N; Kuwabara Y; Nishiwaki T; Kato J; Shinoda N; Sato A; Kimura M; Koyama H; Toyama T; Ishiguro H; Kudo J; Terashita Y; Konishi S; Fujii Y
Jpn J Clin Oncol; 2002 Jul; 32(7):233-7. PubMed ID: 12324572
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis.
Vlotides G; Eigler T; Melmed S
Endocr Rev; 2007 Apr; 28(2):165-86. PubMed ID: 17325339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
